Impact News +++ NWPX Infrastructure to Release Second Quarter 2026 Financial Results on July 29 (PR Newswire) +++ NWPX Aktie -3,31%

DBV TECHNOLOGIES Aktie

>DBV TECH Aktienkurs

2.756 EUR -2.6% (TradegateBSX)

Ask: 2.768 EUR / 400 Stück

Bid: 2.692 EUR / 410 Stück

Tagesumsatz: 955 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

DBV TECH Aktie über LYNX handeln

Intraday

1 Jahr

>DBV TECH Performance

1 Woche: -5,8%

1 Monat: -14,5%

3 Monate: -26,2%

6 Monate: -11,5%

1 Jahr: +58,4%

laufendes Jahr: -16,2%

>DBV TECHNOLOGIES Aktie

Profil:

DBV Technologies SA is a clinical-stage French biopharmaceutical company headquartered in Bagneux, specializing in immunotherapy for food allergies. It pioneers the Viaskin technology, an epicutaneous patch that delivers allergens like peanut or milk..
>Volltext..

Insiderhandel:

>DBV TECH Kennzahlen

Aktien/ Unternehmen:

Analysten:

Bewertung:

Rentabilität:

Managementeffizenz:

>DBV TECH Peer Group

Gesundheit, Hauterkrankungen & -behandlung/ Dermatologie, Allergiebehandlung

>DBV TECH Chart & Kurs - Tradegate

>DBV TECH News

14.07.26 - 22:33	DBV Technologies to Report Second Quarter 2026 Financial Results and Business Update on July 16, 2026 (GlobeNewswire EN)
	Ch'tillon, France, July 14, 2026...

06.07.26 - 22:33	Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF (GlobeNewswire EN)
	AMF Regulated InformationCh'tillon, France, July 6, 2026...

29.06.26 - 22:03	DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing (GlobeNewswire EN)
	Ch'tillon, France, June 29, 2026...

23.06.26 - 22:33	DBV Technologies Announces Inclusion in the Euronext Tech Leaders Index (GlobeNewswire EN)
	Ch'tillon, France, June 23, 2026...

15.06.26 - 15:15	DBV Technologies (DBVT) Soars 5.3%: Is Further Upside Left in the Stock? (Zacks)
	DBV Technologies (DBVT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term....

09.06.26 - 13:03	DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference (GlobeNewswire EN)
	Ch'tillon, France, June 9, 2026...

08.06.26 - 22:39	DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026 (GlobeNewswire EN)
	Ch'tillon, France, June 8, 2026...

05.06.26 - 22:33	DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference (GlobeNewswire EN)
	Ch'tillon, France, June 5, 2026...

03.06.26 - 22:33	DBV Technologies Announces the Results of its 2026 Combined General Meeting (GlobeNewswire EN)
	Ch'tillon, France, June 3, 2026...

03.06.26 - 01:42	DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy (GlobeNewswire EN)
	Ch'tillon, France, June 2, 2026...

12.05.26 - 22:33	DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq (GlobeNewswire EN)
	Ch'tillon, France, May 12, 2026...

30.04.26 - 23:12	DBV Technologies GAAP EPS of -$0.11 (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

30.04.26 - 22:36	DBV Technologies Reports First Quarter 2026 Financial Results (GlobeNewswire EN)
	Ch'tillon, France, April 30, 2026...

14.04.26 - 19:45	DBV Technologies (DBVT) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
	DBV Technologies (DBVT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term....

14.04.26 - 17:30	Wall Street Analysts Predict a 79.04% Upside in DBV Technologies (DBVT): Here′s What You Should Know (Zacks)
	The mean of analysts' price targets for DBV Technologies (DBVT) points to a 79% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock....

27.03.26 - 10:21	DBV Technologies GAAP EPS of -$1.05 (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

26.03.26 - 22:21	DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document (GlobeNewswire EN)
	Ch'tillon, France, March 26, 2026...

26.03.26 - 22:09	DBV Technologies Reports Full Year 2025 Financial Results and Business Update (GlobeNewswire EN)
	Ch'tillon, France, March 26, 2026...

24.03.26 - 21:33	DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review (GlobeNewswire EN)
	Ch'tillon, France, March 24, 2026...

04.03.26 - 22:33	DBV Technologies to Participate in Upcoming March Investor Conferences (GlobeNewswire EN)
	Ch'tillon, France, March 4, 2026...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Wer erwartet, daß in der Welt die Teufel mit Hörnern und die Narren mit Schellen einhergehen, wird stets ihre Beute oder ihr Spiel sein. - Arthur Schopenhauer

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram